• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Investig . Differences between influenza and COVID-19 patients who required hospitalization: A study of the 2024-2025 season

tetano

Editor, Senior Moderator
Respir Investig


. 2025 Sep 30;63(6):1210-1214.
doi: 10.1016/j.resinv.2025.09.012. Online ahead of print. Differences between influenza and COVID-19 patients who required hospitalization: A study of the 2024-2025 season

Naoyuki Miyashita[SUP] 1 [/SUP], Yasushi Nakamori[SUP] 2 [/SUP], Makoto Ogata[SUP] 3 [/SUP], Naoki Fukuda[SUP] 3 [/SUP], Akihisa Yamura[SUP] 3 [/SUP], Tomoki Ito[SUP] 3 [/SUP]



Affiliations
Abstract

Background: During the winter and spring of 2024-2025, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XEC subvariant became the main cause of the epidemic, and at the same time, major influenza epidemics were also observed. To clarify the differences between COVID-19 and influenza, we conducted a comparative study of patients who required hospitalization during the same period.
Methods: We compared 193 patients with COVID-19 Omicron XEC subvariant and 98 patients with influenza H1N1 pdm09 who required hospitalization.
Results: The following characteristics were significantly more common in the COVID-19 group than in the influenza group: 1) males, 2) patients with chronic kidney disease, malignant tumors, autoimmune diseases, and patients using immunosuppressants, 3) patients with multiple underlying diseases, 4) healthcare-associated pneumonia, 5) pure viral pneumonia, 6) aspiration pneumonia, 7) cases in which antivirals had not been used since the diagnosis of infection, 8) patients who required invasive mechanical ventilation management or intensive care unit admission, and 9) deaths. On the other hand, the following characteristics were significantly more frequently observed in the influenza group than in the COVID-19 group: 1) patients without underlying diseases, 2) patients who had been vaccinated within the past year, 3) community-acquired pneumonia, and 4) mixed bacterial pneumonia.
Conclusions: There were many differences between the COVID-19 group and the influenza group that required hospitalization. The rates of severe illness and mortality in the elderly remain high in the COVID-19 group.

Keywords: H1N1 pdm09; Influenza; Omicron variant; SARS-CoV-2; XEC subvariant.

 
Back
Top Bottom